Insider trades
Christine Ring, CLO of Nurix Therapeutics NRIX, has filed 0 purchases and 47 sales on the open market. Over the past 12 months that comes to a net sale of $2.4M. The latest trade was on 06/25.
Christine Ring
Chief Legal Officer
- Company
- Nurix Therapeutics NRIX
- First filing
- 23/02/01
- Trades
- 177 trades
- Buys / sales
- 0 / 47
- 12-month net buying
- −$2.4M
- Last trade
- 06/25
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 06/25 | 06/25 | 28,935 sh | $20.06 | $580,436.1 | −68.1% | |
| Open-market sale10b5-1 plan | 06/02 | 06/02 | 8,148 sh | $16.60 | $135,256.8 | −37.5% | |
| Open-market sale10b5-1 plan | 05/04 | 05/04 | 8,148 sh | $16.96 | $138,190.08 | −30.8% | |
| Open-market sale10b5-1 plan | 05/01 | 05/01 | 5,394 sh | $16.76 | $90,403.44 | −16.9% | |
| Open-market sale | 04/30 | 04/30 | 3,214 sh | $16.65 | $53,513.1 | −9.2% | |
| Open-market sale10b5-1 plan | 04/02 | 04/02 | 8,148 sh | $15.24 | $124,175.52 | −23.5% | |
| Open-market sale10b5-1 plan | 03/02 | 03/02 | 8,148 sh | $15.44 | $125,805.12 | −19.1% | |
| Open-market sale10b5-1 plan | 02/09 | 02/09 | 14,261 sh | $16.66 | $237,588.26 | −25.0% | |
NRIX | Open-market sale | 01/30 | 01/30 | 4,421 sh2 trades | $16.60avg. | $73,369.7 | −7.2% |
| Open-market sale10b5-1 plan | 01/20 | 01/20 | 3,760 sh | $18.42 | $69,259.2 | −6.9% | |
NRIX | Open-market sale10b5-1 plan | 25/12/18 | 25/12/18 | 3,760 sh2 trades | $17.91avg. | $67,329.2 | −6.9% |
| Open-market sale10b5-1 plan | 25/11/24 | 25/11/24 | 37,600 sh | $17.07 | $641,832 | −42.5% | |
| Open-market sale | 25/10/30 | 25/10/30 | 3,644 sh | $12.80 | $46,643.2 | −6.7% | |
| Open-market sale | 25/07/30 | 25/07/30 | 3,841 sh | $12.01 | $46,130.41 | −8.0% | |
| Open-market sale | 25/04/30 | 25/04/30 | 2,894 sh | $11.50 | $33,281 | −7.2% | |
NRIX | Open-market sale10b5-1 plan | 25/01/31 | 25/02/03 | 5,760 sh2 trades | $19.95avg. | $114,908.4 | −15.0% |
NRIX | Open-market sale | 25/01/30 | 25/01/30 | 3,220 sh2 trades | $19.86avg. | $63,939.52 | −9.0% |
| Open-market sale10b5-1 plan | 25/01/02 | 25/01/02 | 5,760 sh | $19.50 | $112,320 | −17.0% | |
| Open-market sale10b5-1 plan | 24/12/02 | 24/12/02 | 5,760 sh | $21.73 | $125,164.8 | −17.0% | |
| Open-market sale10b5-1 plan | 24/11/04 | 24/11/04 | 3,290 sh | $25.00 | $82,250 | −10.5% |